Opaleye Management Inc. Tela Bio, Inc. Transaction History

Opaleye Management Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.85 - $10.68 $6.52 Million - $8.86 Million	-830,000 Reduced 52.53%	750,000 $6 Million
Q2 2023 Aug 14, 2023	SELL	$9.23 - $11.23 $4.55 Million - $5.53 Million	-492,813 Reduced 23.78%	1,580,000 $16 Million
Q4 2022 Feb 10, 2023	BUY	$6.5 - $11.5 $235,703 - $417,013	36,262 Added 1.78%	2,072,813 $23.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $2.89 Million - $3.6 Million	393,184 Added 23.93%	2,036,551 $17.4 Million
Q2 2022 Aug 15, 2022	BUY	$5.54 - $11.49 $6.46 Million - $13.4 Million	1,166,367 Added 244.52%	1,643,367 $11.5 Million
Q1 2022 May 16, 2022	BUY	$11.35 - $13.7 $307,959 - $371,722	27,133 Added 6.03%	477,000 $5.55 Million
Q4 2021 Feb 14, 2022	BUY	$11.95 - $13.34 $79,682 - $88,951	6,668 Added 1.5%	449,867 $5.76 Million
Q3 2021 Nov 16, 2021	BUY	$12.2 - $15.93 $33,354 - $43,552	2,734 Added 0.62%	443,199 $6.05 Million
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $882,940 - $1.22 Million	75,465 Added 20.68%	440,465 $7.1 Million
Q4 2020 Feb 12, 2021	BUY	$14.61 - $17.59 $42,748 - $51,468	2,926 Added 0.81%	365,000 $5.49 Million
Q3 2020 Nov 16, 2020	BUY	$11.64 - $16.86 $1.3 Million - $1.89 Million	112,074 Added 44.83%	362,074 $5.99 Million
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $1.31 Million - $3.82 Million	169,000 Added 208.64%	250,000 $3.24 Million
Q1 2020 May 15, 2020	SELL	$5.39 - $18.33 $506,659 - $1.72 Million	-94,000 Reduced 53.71%	81,000 $633,000
Q4 2019 Feb 14, 2020	BUY	$11.26 - $13.8 $1.97 Million - $2.42 Million	175,000 New	175,000 $2.27 Million

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $51.5M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.